how many people take glp-1 Weight loss changes more than the number on the scale. As medications become more common, are asking an important question: Am I losing fat, muscle, or both? Two people The risk too many people
Description
FDA has a more rapid approach for approval of chronic weight management drugs, permitting short phase 3 trials of 52 to 68 weeks without requiring pre-approval cardiovascular outcomes trials (CVOTs) whereas Europe insists on such trials
In a controlled crossover feeding study, a high-GI meal selectively increased activation in reward and craving regions four hours postprandially compared with an isocaloric low-GI meal, independent of palatability [26]
Opportunity to serve users According to the European Medicines Agency, there are currently three branded GLP-1 drugs approved for use in weight management in Europe: Saxenda, Wegovy and Mounjara
for related research
Love not having to drive to the doctors office, sit through long waits, etc. Verified Patient Lisa, OH Incredible
